Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01820325 |
Title | Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer |
Acronym | BASALT-2 |
Recruitment | Terminated |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Novartis|Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | ESP | DEU | CAN |